Exercise, cognition and Alzheimer's disease: More is not necessarily better

Neuroscience and Biobehavioral Reviews

Volumn 30, Issue 4, 2006, Pages 562-575

  Eggermont, Laura ^a   Swaab, Dick ^b   Luiten, Paul ^c   Scherder, Erik ^c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Alzheimer's disease; Cerebral perfusion; Cognition; Exercise; Nitric oxide; Physical activity

Indexed keywords

NITRIC OXIDE; TISSUE PLASMINOGEN ACTIVATOR;

ALZHEIMER DISEASE; BRAIN METABOLISM; BRAIN NERVE CELL; BRAIN PERFUSION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL OBSERVATION; COGNITION; COGNITIVE DEFECT; DEMENTIA; EXERCISE; HUMAN; INFORMATION RETRIEVAL; PATIENT SELECTION; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT;

ALZHEIMER DISEASE; ANIMALS; CEREBROVASCULAR CIRCULATION; COGNITION; EXERCISE; HUMANS; NITRIC OXIDE;

EID: 33646186499     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2005.10.004     Document Type: Review

References (135)

1. Adlard P.A., Perreau V.M., Pop V., and Cotman C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25 (2005) 4217-4221
2. Alessi C.A., Yoon E.J., Schnelle J.F., Al Samarrai N.R., and Cruise P.A. A randomized trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve?. J. Am. Geriatr. Soc. 47 (1999) 784-791
3. Anton E.S., Sandrock Jr. A.W., and Matthew W.D. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vitro: evidence using an antibody to merosin, ARM-1. Dev. Biol. 164 (1994) 133-146
4. Attwell D., and Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci. 25 (2002) 621-625
5. Baumbach G.L., and Heistad D.D. Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ. Res. 52 (1983) 527-533
6. Bierman E.J., Comijs H.C., Jonker C., and Beekman A.T. Effects of anxiety versus depression in later life. Am. J. Geriatr. Psychiatry 13 (2005) 686-693
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
8. Chen Z.-L., and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91 (1997) 917-925
9. Chen Y., McCarron R.M., Bembry J., Ruetzler C., Azzam N., Lenz F.A., and Spatzm M. Nitric oxide modulates endothelin 1-induced Ca2+ mobilization and cytoskeletal F-actin filaments in human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 19 (1999) 133-138
10. Churchill J.D., Galvez R., Colcombe S., Swain R.A., Kramer A.F., and Greenough W.T. Exercise, experience, and the aging brain. Neurobiol. Aging 23 (2002) 941-955
11. Cohen J. A power primer. Psychol. Bull. 112 (1992) 155-159
12. Colcombe S., and Kramer A.F. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol. Sci. 14 (2003) 125-130
13. Cooke J.P., and Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48 (1997) 489-509
14. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericakvance M.A. Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late-onset families. Science 261 (1993) 921-923
15. Cott C.A., Dawson P., Sidani S., and Wells D. The effects of a walking/talking program on communication, Ambulation, and Functional Status in Residents with Alzheimer Disease. Alzheimer Dis. Assoc. Disord. 16 (2002) 81-87
16. Critchley H.D., Corfield D.R., Chandler M.P., Mathias C.J., and Dolan R.J. Cerebral correlates of autonomic cardiovascular arousal: a functional neuroimaging investigation in humans. J. Physiol. 523 (2000) 259-270 (of norm-adjusted versus fixed cut-points. Int. J. Geriatr. Psychiatry 20, 371-376)
17. Cumming J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gorngein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
18. Daley M.L., Pourcyrous M., Timmons S.D., and Leffler C.W. Assessment of cerebrovascular autoregulation. Changes of highest modal frequency of cerebrovascular pressure transmission with cerebral perfusion pressure. Stroke 35 (2004) 1952-1956
19. De la Torre J.C. Vascular basis of Alzheimer's Pathogenesis. Ann. NY Acad. Sci. 977 (2002) 196-215
20. Diesfeldt H.F.A., and Diesfeldt-Groenendijk H. Improving cognitive performance in psychogeriatric patients: the influence of physical exercise. Age Ageing 6 (1977) 58-64
21. Dubelaar E.J.G., Verwer R.W.H., Hofman M.A., Van Heerikhuize J.J., Ravid R., and Swaab D.F. ApoE epsilon 4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J. Neuropathol. Exp. Neurol. 63 (2004) 159-169
22. Eldridge C.F., Bunge M.B., and Bunge R.P. Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina. J. Neurosci. 9 (1989) 625-638
23. Endres M., Gertz K., Lindauer U., Katchanov J., Schultze J., Schröck H., Nickenig G., Kuschinsky W., Dirnagl U., and Laufs U. Mechanisms of stroke protection by physical activity. Ann. Neurol. 54 (2003) 582-590
24. Farkas E., and Luiten P.G.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001) 575-611
25. Fedele E., and Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/Cgmp pathway. Prog. Neurobiol. 58 (1999) 89-120
26. Fernández-Vizarra P., Fernández A.P., Castro-Blanco S., Encinas J.M., Serrano J., Bentura M.L., Muñoz P., Martínez-Murillo R., and Rodrigo J. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol. Dis. 15 (2004) 287-305
27. Folstein M.F., Folstein S.E., and Mchugh P.R. Mini-mental state. A practical method for grading cognitive state of patients for clinician. J. Psychiatr. Res. 12 (1975) 189-198
28. Fratiglioni L., Paillard-Borg S., and Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 3 (2004) 343-353
29. Friedman R., and Tappen R.M. The effect of planned walking on communication in Alzheimer's disease. J. Am. Geriatr. Soc. 39 (1991) 650-654
30. Graham F.K., and Kendall B.S. Memory-for-Designs Test: revised general manual. Percept. Mot. Skills 11 (1960) 147-188
31. Guigoz Y., Vellas B., and Garry P.J. Mini Nutritional Assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res. Gerontol. 4 (1994) 113-143
32. Hamel E. Cholinergic modulation of the cortical microvascular bed. Prog. Brain Res. 145 (2004) 171-178
33. Harkany T., Penke B., and Luiten P.G.M. Beta-amyloid excitotoxicity in rat magnocellular nucleus basalis-Effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer's disease. Ann. NY Acad. Sci. 903 (2000) 374-386
34. Hayward R., Ruangthai R., Karnilaw P., Chicco A., Strange R., McCarty H., and Westerlind K.C. Attenuation of homocysteine-induced endothelial dysfunction by exercise training. Pathophysiology 9 (2003) 207-214
35. Hellström G., Fischer-Colbrie W., Wahlgren N.G., and Jogestrand T. Carotid artery blood flow and middle cerebral artery blood flow velocity during physical exercise. J. Appl. Physiol. 81 (1996) 413-418
36. Herrmann M. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin. Chem. Lab. Med. 8 (2001) 666-674
37. Herrmann M., Schorr H., Obeid R., Scharhag J., Urhausen A., Kindermann W., and Herrmann W. Homocysteine increases during endurance exercise. Clin. Chem. Lab. Med. 41 (2003) 1518-1524
38. Hoffman S.B., Platt C.A., and Barry K.E. Senile Dementia of the Alzheimer's Type (1985), Alan Liss, New York
39. Hönigfeld G., Gillis R.D., and Klett C.J. NOSIE-30: a treatment-sensitive ward behaviour scale. Psychol. Rep. 19 (1966) 180-182
40. Huang P.L., Huang Z.H., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., and Fishman M.C. Hypertension in mice lacking the gene for endothelial Nitric-Oxide synthase. Nature 377 (1995) 239-242
41. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5 (2004) 347-360
42. Ide K., and Secher N.H. Cerebral blood flow and metabolism during exercise. Prog. Neurobiol. 61 (2000) 397-414
43. Ide K., Pott F., Van Lieshout J.J., and Secher N.H. Middle cerebral artery blood velocity depends on cardiac output during exercise with a large muscle mass. Acta Physiol. Scand. 162 (1998) 13-20
44. Ide K., Horn A., and Secher N.H. Cerebral metabolic response to submaximal exercise. J. Appl. Physiol. 87 (1999) 1604-1608
45. Jagust W.J., Eberling J.L., Reed B.R., Mathis C.A., and Budinger T.F. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. NY Acad. Sci. 826 (1997) 254-262
46. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., and Albert M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50 (1998) 1563-1571
47. Jørgensen L.G., Perko G., and Secher N.H. Regional cerebral-artery mean flow velocity and blood-flow during dynamic exercise in humans. J. Appl. Physiol. 73 (1992) 1825-1830
48. Katz S. Assessing self maintenance: activities of daily living, mortality and instrumental activities of daily living. J. Am. Geriatr. Soc. 31 (1983) 721-727
49. Keller K., and Lemberg L. Retirement is no excuse for physical inactivity or isolation. Am. J. Crit. Care 11 (2002) 270-272
50. Kivipelto M., Laakso M.P., Tuomilehto J., Nissinen A., and Soininen H. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease-potential for pharmacological intervention. CNS Drugs 16 (2002) 435-444
51. Koike A., Itoh H., Oohara R., Hoshimoto M., Tajima A., Aizawa T., and Long T.F. Cerebral oxygenation during exercise in cardiac patients. Chest 125 (2004) 182-190
52. Koistinaho M., and Koistinaho J. Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation. Brain Res. Brain Res. Rev. 48 (2005) 240-250
53. Kubes P., and Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (1992) H611-H615
54. Kurosawa M., Okada K., Sato A., and Uchida S. Extracellular release of acetylcholine, noradrenaline and serotonin increases in the cerebral-cortex during walking in conscious rats. Neurosci. Lett. 161 (1993) 73-76
55. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., and Havlik R.J. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging 21 (2000) 49-55
56. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
57. Lazowski D., Ecclestone N.M.A., Paterson D., Tudor-Locke C., Fitzgerald C., Jones G., Shima N., and Cunnigham D. A randomized outcome evaluation of group exercise programs in long-term care institutions. J. Gerontol. A Biol. Sci. Med. Sci. 54 (1999) M621-M628
58. Lehtovirta M., Kuikka J., Helisalmi S., Hartikainen P., Mannermaa A., Ryynanen M., Riekkinen P.S., and Soininen H. Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J. Neurol. Neurosurg. Psychiatry 64 (1998) 742-746
59. Liesi P., Narvanen A., Soos J., Sariola H., and Snounou G. Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides. FEBS Lett. 244 (1989) 141-148
60. Lijnen H.R., and Collen D. Endothelium in hemostasis and thrombosis. Prog. Cardiovasc. Dis. 39 (1997) 343-350
61. Lindenmuth G.F., and Moose B. Improving cognitive abilities of elderly Alzheimer's patients with intense exercise therapy. Am. J. Alzheimers Care Relat. Dis. Res. 5 (1990) 31-33
62. MacRae P.G., Asplund L.A., Schnelle J.F., Ouslander J.G., Abrahamse A., and Morris C. A walking program for nursing home residents: effects on walk endurance, physical activity, mobility, and quality of life. J. Am. Geriatr. Soc. 44 (1996) 175-180
63. Martel C.L., Mackic J.B., Matsubara E., Governale S., Miguel C., Miao W., McComb J.G., Frangione B., Ghiso J., and Zlokovic B.V. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid β. J. Neurochem. 69 (1997) 1995-2004
64. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann. Nucl. Med. 15 (2001) 85-92
65. Matsuda K., Tashiro K., Hayashi Y., Monji A., Yoshida I., and Mitsuyama Y. Measurement of laminins in the cerebrospinal fluid obtained from patients with Alzheimer's disease and vascular dementia using a modified enzyme-linked immunosorbent assay. Dement. Geriatr. Cogn. Disord. 14 (2002) 113-122
66. Maxwell A.J. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6 (2002) 101-124
67. Melchor J.P., Pawlak R., and Strickland S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-β (Aβ) degradation and inhibits Aβ-induced neurodegeneration. J. Neurosci. 23 (2003) 8867-8871
68. Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., and Reynolds C.F. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18 (1998) 407-430
69. Meyer J.S., Rauch G.M., Rauch R.A., Haque A., and Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann. NY Acad. Sci. 903 (2000) 411-423
70. Miklossy J. Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol. Res. 25 (2003) 605-610
71. Monji A., Yoshida I., Tashiro K., Hayashi Y., Matsuda K., and Tashiro N. Inhibition of Aβ fibril formation and Aβ-induced cytotoxicity by senile plaque-associated proteins. Neurosci. Lett. 278 (2000) 81-84
72. Morgan C., and Inestrosa N.C. Interactions of laminin with the amyloid β peptide. Implications for Alzheimer's disease. Braz. J. Med. Biol. Res. 34 (2001) 597-601
73. Moro V., Badaut J., Springhetti V., Edvinsson L., Seylaz J., and Lasbennes F. Regional study of the co-localization of neuronal nitric-oxide synthase with muscarinic receptors in the rat cerebral cortex. Neuroscience 69 (1995) 797-805
74. Mulder J.L., Dekker R., and Dekker P.H. Verbale Leer-en Geheugentest (Verbal Learning and Memory Test) (1995), Swets & Zeitlinger, Lisse, The Netherlands
75. Muldowney J.A.S., and Vaughan D.E. Tissue-type plasminogen activator release. New frontiers in endothelial function. J. Am. Coll. Cardiol. 40 (2002) 967-969
76. Nagahama Y., Nabatame H., Okina T., Yamauchi H., Narita M., Fujimoto N., Murakami M., Fukuyama H., and Matsuda M. Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur. Neurol. 50 (2003) 1-9
77. Nagai N., De Mol M., Lijnen H.R., Carmeliet P., and Collen D. Role of plasminogen system components in focal cerebral ischemic infarction. A gene targeting and gene transfer study in mice. Circulation 99 (1999) 2440-2444
78. Nakajima K., Uchida S., Suzuki A., Hotta H., and Aikawa Y. The effect of walking on regional blood flow and acetylcholine in the hippocampus in conscious rats. Auton. Neurosci. 103 (2003) 83-92
79. Namazi K.H., Zadorozny C.A., and Gwinnup P.B. The influences of physical activity on patterns of sleep behavior of patients with Alzheimer's disease. Int. J. Aging Hum. Dev. 40 (1995) 145-153
80. Naso F., Carner E., Blankfortdoyle W., and Coughey K. Endurance training in the elderly nursing home patient. Arch. Phys. Med. Rehabil. 71 (1990) 241-243
81. Palleschi L., Vetta F., DeGennaro E., Idone G., Sottosanti G., Gianni W., and Marigliano V. Effect of aerobic training on the cognitive performance of elderly patients with senile dementia of Alzheimer type. Arch. Gerontol. Geriatr. Suppl. 5 (1996) 47-50
82. Palmer C. Exercise as a treatment for depression in elders. J. Am. Acad. Nurse Pract. 17 (2005) 60-66
83. Parihar M.S., and Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11 (2004) 456-467
84. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
85. Plutchik R., Conte H., Lieberman M., Bakur M., Grossman J., and Lehrman N. Reliability and validity of a scale for assessing functioning of geriatric patients. J. Am. Geriatr. Soc. 18 (1970) 491-500
86. Pober D.M., Braun B., and Freedson P.S. Effects of a single bout of exercise on resting heart rate variability. Med. Sci. Sports Exerc. 36 (2004) 1140-1148
87. Pott F., Knudsen L., Nowak M., Nielsen H.B., Hanel B., and Secher N.H. Middle cerebral artery blood velocity during rowing. Acta Physiol. Scand. 160 (1997) 251-255
88. Powell R.R. Psychological effects of exercise therapy upon institutionalized geriatric mental patients. J. Gerontol. 29 (1974) 157-164
89. Prager G.W., Breuss J.M., Steurer S., Mihaly J., and Binder B.R. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 103 (2004) 955-962
90. Prunell G.F., Mathiesen T., and Svendgaard N.A. Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 54 (2004) 426-436
91. Raven J.C. Guide to using the coloured progressive matrices, sets A, Ab B (1965), WilliamGrieve & Sons, Dumfries, Scotland
92. Reiman E.M., Caselli R.J., Yun L.S., Chen K.W., Bandy D., Minoshima S., Thibodeau S.N., and Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New Engl. J. Med. 334 (1965) 752-758
93. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychology Test Battery (1985), Neuropsychology Press, Tucson, ZA
94. Rolland Y., Rival L., Pillard F., Lafont C.H., Riviere D., Albarede J.-L., and Vellas B. Feasibility of regular physical exercise for patients with moderate to severe Alzheimer disease. J. Nutr. Health Aging 4 (2000) 109-113
95. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., and Goddard R. Camdex-A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149 (1986) 698-709
96. Salehi A., Dubelaar E.J.G., Mulder M., and Swaab D.F. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc. Natl Acad. Sci. USA 95 (1998) 11445-11449
97. Scherder E.J.A., Paasschen J., Deijen J.-B., Van der Knokke S., Orlebeke J.F.K., Burgers I., Devriese P.-P., Swaab D.F., and Sergeant J.A. Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment. Health 9 (2005) 272-280
98. Schini-Kerth V.B. Vascular biosynthesis of nitric oxide: effect on hemostatis and fibrinolysis. Transfus. Clin. Biol. 6 (1999) 355-363
99. Selley M.L. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol. Aging 24 (2003) 903-907
100. Skoog I., and Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol. Res. 25 (2003) 675-680
101. Smith D.T., Hoetzer G.L., Greiner J.J., Stauffer B.L., and DeSouza C.A. Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J. Physiol. 546 (2003) 289-298
102. Sobel B.P. Bingo vs. physical intervention in stimulating short-term cognition in Alzheimer's disease patients. Am. J. Alzheimers Dis. Other Demen. 16 (2001) 115-120
103. Spinler H., and Tognoni G. Standardizzazione e taratura italiana di test Neuropsicologici. Ital. J. Neurol. Sci. Suppl. 8 (1987) 71-95
104. Srikiatkhachorn A., Anuntasethakul T., Maneesri S., Phansuwan-Pujito P., Patumraj S., and Kasantikul V. Hyposerotonin-induced nitric oxide supersensitivity in the cerebral microcirculation. Headache 40 (2000) 267-275
105. Suzuki N., Iwatsubo T., Odaka A., Ishibashi Y., Kitada C., and Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 5 (1994) 452-460
106. Swaab D.F. Brain aging and Alzheimer's disease, wear and tear versus use it or lose it. Neurobiol. Aging 12 (1991) 317-324
107. Swaab D.F. Neuropathology of the human hypothalamus and adjacent structures. Part 2. In: Aminoss M.J., Boller S., and Swaab D.F. (Eds). Handbook of Clinical Neurology vol. 80 (2004), Elsevier, Amsterdam, The Netherlands
108. Swaab D.F., Dubelaar E.J.G., Hofman M.A., Scherder E.J.A., Van Someren E.J.W., and Verwer R.W.H. Brain aging and Alzheimer's disease; use it or lose it. In: Hofman M.A., Boer G.J., Holtmaat A.J.G.D., Van Someren E.J.W., Verhaagen J., and Swaab D.F. (Eds). Progress in Brain Research vol. 138 (2002), Elsevier, Amsterdam, The Netherlands 343-373
109. Swain R.A., Harris A.B., Wiener E.C., Dutka M.V., Morris H.D., Theien B.E., Konda S., Engberg K., Lauterbur P.C., and Greenough W.T. Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience 117 (2003) 1037-1046
110. Tappen R.M. Communication Assessment for the Cognitively Impaired, Instrument (1988), Coral Gables, University of Miami, Miami, FL
111. Tappen R.M., Roach K.E., Applegate E.B., and Stowell P. Effect of a combined walking and conversation intervention on functional mobility of nursing home residents with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14 (2000) 196-201
112. Teri L., McCurry S.M., Buchner D.M., Logsdon R.G., LaCroix A.Z., Kukull W.A., Barlow W.E., and Larson E.B. Exercise and activity level in Alzheimer's disease: a potential treatment focus. J. Rehabil. Res. Dev. 35 (1998) 411-419
113. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Neuropsychological Battery: for cognitive assessment of Alzheimer's disease and other dementing disorders of the elderly and for possible dementia prodrome. Duke University Medical Center, CERAD, 1987.
114. Tinetti M.E., Speechley M., and Ginter S.F. Risk factors of falls among elderly persons living in the community. N. Eng. J. Med. 319 (1988) 1701-1707
115. Tong X.K., and Hamel E. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neuroscience 92 (1999) 163-175
116. Tong X.K., and Hamel E. Basal forebrain nitric oxide synthase (NOS)-containing neurons project to microvessels and NOS neurons in the rat neocortex: cellular basis for cortical blood flow regulation. Eur. J. Neurosci. 12 (2000) 2769-2780
117. Tsolaki M., Sakka V., Gerasimou G., Dimacopoulos N., Chatzizisi O., Fountoulakis K.N., Kyriazis G., Papanastasiou J., and Kazis A. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects. Am. J. Alzheimers Dis. Other Demen. 16 (2001) 21-31
118. Tucker H.M., Kihiko M., Caldwell J.N., Wright S., Kawarabayashi T., Price D., Walker D., Scheff S., McGillis J., Rydel R.E., and Estus S. The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 20 (2000) 3937-3946
119. Tucker H.M., Kihiko-Ehmann M., and Estus S. Urokinase-type plasminogen activator inhibits amyloid-β neurotoxicity and fibrillogenesis via plasminogen. J. Neurosci. Res. 70 (2002) 249-255
120. Ueda H., Kitabayashi Y., Narumoto J., Nakamura K., Kita H., Kishikawa Y., and Fukui K. Relationship between clock drawing test performance and regional cerebral blood flow in Alzheimer's disease: a single photon emission computed tomography study. Psychiatry Clin Neurosci. 56 (2002) 25-29
121. Ushijima Y., Okuyama C., Mori S., Nakamura T., Kubota T., and Nishimura T. Relationship between cognitive function and regional cerebral blood flow in Alzheimer's disease. Nucl. Med. Commun. 23 (2002) 779-784
122. Van de Winckel A., Feys H., and De Weerdt W. Cognitive and behavioural effects of music-based exercises in patients with dementia. Clin. Rehabil. 18 (2004) 253-260
123. Van Dyck C.H. Neuroimaging in Alzheimer's disease: relevance for treatment. Curr. Psychiatry Rep. 3 (2004) 13-19
124. Van Gelder B.M., Tijhuis M.A.R., Kalmijn S., Giampaoli S., Nissinen A., and Kromhout D. Physical activity in relation to cognitive decline in elderly men. The FINE study. Neurology 63 (2004) 2316-2321
125. Wang Y.F., Tsirka S.E., Strickland S., Stieg P.E., Soriano S.G., and Lipton S.A. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischaemia in wild-type and tPA-deficient mice. Nat. Med. 4 (1998) 228-231
126. Warkentin S., Ohlsson M., Wollmer P., Edenbrandt L., and Minthon L. Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity. Dement. Geriatr. Cogn. Disord. 17 (2004) 207-214
127. Wechsler D. A standardized scale for clinical use. J. Psychol. 19 (1945) 87-95
128. Wechsler D. Wechsler Memory-Scale-Revised (1984), The Psychological Corporation, New York
129. Weller R.O., and Nicoll J.A.R. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol. Res. 25 (2003) 611-616
130. Wenk G.L., McGann-Gramling K., Hauss-Wegrzyniak B., Ronchetti D., Maucci R., Rosi S., Gasparini L., and Ongini E. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J. Neurochem. 89 (2004) 484-493
131. Whelton S.P., Chin A., Xin X., and He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann. Intern. Med. 136 (2002) 493-503
132. White R.P., Vallance P., and Markus H.S. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin. Sci. 99 (2000) 555-560
133. Wilson B., Cockburn J., and Baddeley A. The Rivermead Behavioural Memory Test (1987), Thames Valley Test Company, Titchfield, England
134. Wolf R.L., Alsop D.C., Levy-Reis I., Meyer P.T., Maldjian J.A., Gonzalez-Atavales J., French J.A., Alavi A., and Detre J.A. Detection of mesial temporal lobe hypoperfusion in patients with temporal spin labeled lobe epilepsy by use of arterial perfusion MR imaging. Am. J. Neuroradiol. 22 (2001) 1334-1341
135. Zarit S.H., Todd P.A., and Zarit J.M. Families under stress: interventions for caregivers of senile dementia patients. Psychotherapy 19 (1982) 461-471